Leukostasis

Last revised by Yuranga Weerakkody on 30 Aug 2023

Leukostasis, also known as symptomatic hyperleukocytosis, is a medical emergency in patients with leukaemia, particularly acute myeloid leukaemia (AML) and in the blast phase of chronic myeloid leukaemia (CML), characterised by the over-accumulation of leukaemic cells within the small vessels. Although it potentially affects any organ, the lungs, and the brain are the most commonly involved, presenting with symptoms due to vascular occlusion. 

It is most commonly seen as a complication of white blood cell counts over 100 x 109/L (100,000/microL) 4.

It needs to be considered in any patient with myelogenous leukaemia with an acute onset dyspnoea and normal chest radiograph or pulmonary oedema. Symptoms are due to obstruction of small pulmonary vessels or coronary artery(ies) by leukaemic cells.

Thoracic features include

  • normal chest radiograph 4
  • pulmonary oedema 4
  • usually, no evidence of interstitial infiltrates

Leukostasis is an emergency and commonly managed with leukapheresis to remove the excess of leukaemic cells in circulation 4

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.